Pomolidomide for relapsed/refractory light chain amyloidosis after resistance to both bortezomib and daratumumab: A case report

BACKGROUND: Immunoglobulin light chain (AL) amyloidosis is a rare disease characterized by deposition of ALs essentially in any organ or tissue, with cardiac involvement being very frequent (61%). Early diagnosis is of high importance because early initiation of treatment in AL amyloidosis may impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xian, Pan, Xiao-Hong, Fang, Qiu, Liang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791522/
https://www.ncbi.nlm.nih.gov/pubmed/36579116
http://dx.doi.org/10.12998/wjcc.v10.i34.12703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791522/
https://www.ncbi.nlm.nih.gov/pubmed/36579116
http://dx.doi.org/10.12998/wjcc.v10.i34.12703

Ejemplares similares